ClinConnect ClinConnect Logo
Search / Trial NCT04046523

Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy

Launched by UNIVERSITY OF MINNESOTA · Aug 2, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Video Ophthalmoscope Intraocular Pressure Electrocardiogram Photoplethysmography Retinal Pulsatility Spontaneous Venous Pulsation Blind Source Separation

ClinConnect Summary

This clinical trial is studying a new way to measure intracranial pressure—essentially the pressure inside the skull—using a special camera called a video ophthalmoscope. This method is non-invasive, meaning it doesn’t require any surgical procedures or direct contact with the eye, and it doesn’t involve anesthesia. The goal is to find out if this method can give doctors useful information about intracranial pressure in patients who already have a monitoring device in place for medical reasons.

To participate in this trial, individuals need to be between the ages of 14 and 60 and must be able to sit still and focus their eyes on a target during the test. Those with certain eye conditions like glaucoma or retinopathy, or who have head tremors, will not be eligible. If you or someone you know qualifies and chooses to participate, you can expect a straightforward process where your intracranial pressure will be assessed without any discomfort or invasive techniques. This research could help improve how we monitor intracranial pressure in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Must be able to sit still and fix their eyes on a target in the VO objective.
  • ICP participants must have an inserted ICP probe for clinical purposes.
  • Exclusion Criteria:
  • Diagnosis of glaucoma, retinopathy or head tremor.

About University Of Minnesota

The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.

Locations

Minneapolis, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Igor Nestrasil, MD, PhD

Principal Investigator

University of Minnesota

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials